Screener/Healthcare/Biotechnology

PVLA

Palvella Therapeutics, Inc.NASDAQ
$118.25+1.21 (+1.03%)
$18.23
$151.18
$113.00
$118.64
EPS (TTM)$-1.62
P/E Ratio
Dividend Yield
Market Cap$1.63B
Volume237K
Prev Close$117.04
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$628K-$11.3M$-1.03-1806.5%
Q2 '25$690K-$9.5M$-0.86-1372.6%
Q1 '25$752K-$8.2M$-0.74-1088.4%
Q4 '24-$53K-$6.1M$1.0111443.4%
Get Your Daily Market Recap